Authors


Robert Caruso

Latest:

Developments in Scanning Electron Microscopy for Tablet and Granule Characterization

Recent advances in SEM, particularly the incorporation of automation and software, have made simpler, lower-end SEM instruments easy to operate and have improved the capabilities of larger, sophisticated instruments.


Wendy Alderton

Latest:

Zebrafish: a multifaceted approach for drug safety assessment

Many compounds fail in preclinical development because of safety-related problems, but identifying 'predictable' safety or toxicity liabilities earlier in the process could lead to improved design and selection of compounds that are more likely to be approved.



Darren Jackson

Latest:

An Integrated Approach to Bioinformatics

During the last few decades, advances in molecular biology have allowed the increasingly rapid sequencing of large portions of genomes. The plethora of information, resulting from programmes such as the Human Genome Project, has necessitated the careful storage, organization and indexing of sequence information. This, in turn, has led to the development of numerous sequence databases such as GenBank and EMBL. This article examines how an integrated approach to bioinformatics could help researchers align their work, share data and, ultimately, significantly increase productivity.


Imre Szabo

Latest:

Efficient logistic operations

Ask the Expert looks at logistic problems.


Inese Lowenstein

Latest:

Upcoming technologies to facilitate more efficient biologics manufacturing

The number of biotechnology-based human therapeutic products in the late-stage pipeline along with the average cost to commercialize a biotech product has been steadily increasing with time. In addition, the biotech industry is facing unprecedented challenges of a sagging global economy and rising regulatory expectations. Companies have to continue to evolve their approaches to be more efficient with respect to time, resources and cost. This article describes some of the technologies that can help optimize time and cost of biopharmaecutical manufacturing.


Brian D. Smith

Latest:

Promoting a peaceful workplace

Conflict between departments costs money, wastes time and hinders strategy implementation. But we can reduce it and manage it if we understand it, says Dr Brian D. Smith.


Frank Milek

Latest:

Supply-Chain Security of Pharmaceutical Starting Materials

IPEC Europe continues to promote the quality, safety and functionality of excipients used in pharmaceutical products.


Joseph F. deSpautz

Latest:

Managing the risks of PAT

Operational excellence awaits, but only if you can implement PAT successfully.


John P. Jasper

Latest:

Evaluating Practical Uses of Molecular Isotopic Engineering

The authors' directed isotopic synthesis is one example of how molecular isotopic engineering can be used to predetermine the discrete isotopic ranges of biopharmaceutical products.


Norma Leyva

Latest:

Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data

The authors present a simple and material-sparing approach for estimating the powder-flow performance of previously uncharacterized single-component bulk powders when only particle-size distribution data are available.


Karel Bastiaanssen

Latest:

Efficient logistic operations

Ask the Expert looks at logistic problems.


Elizabeth Colbourn

Latest:

Use of Artificial Neural Networks and Genetic Algorithms - Experiences from a Tablet Formulation

This article describes the formulation of a tablet for a specific purpose, primarily using fractional or full factorial designs. The formulation work generated a matrix that was processed by two software packages based on neural networks. When the dataset was divided into smaller subsets, the agreement between the predicted and observed tablet properties of the optimized formulations was reasonable.


Chris Pickles

Latest:

Manufacturing problems

Many industries, from aerospace to medical devices, conduct cleaning procedures.


Mike Butler

Latest:

Hypothesis to acceptance

During the last 20 years, pharmaceutical R&D spending has increased 15-fold while new product approvals have increased only 0.70-fold.


Peter Tell

Latest:

Keeping It Together: Reducing Powder Segregation in Vacuum Conveying

Vacuum-conveying technology is commonly used in the pharmaceutical industry to move materials through the processing line, blend ingredients in various solutions, and handle tablets. The vacuum conveying of powders and granules, however, must be performed properly to avoid segregation, the separation of ingredients that results in an uneven mixture.


J. Kevin O'Donnell

Latest:

Qualification of a Chromotographic Column

In this article, five industry experts share their insights to ensure that your column qualification protocols can survive the increased scrutiny of FDA inspectors.


Philippe Cini

Latest:

Predictive modelling: putting ICH guidelines to work in process validation

When applied as part of a structured approach, predictive modelling can provide deep process and product understanding, and can enable true, continuous process validation as envisioned by ICH guidelines.


François Becher

Latest:

Bioanalysis of recombinant proteins by mass spectrometry

Biotechnological developments have led to an increased number of recombinant proteins or antibodies in drug development that offer high potential in various diseases, such as cancer, growth disturbances and diabetes.


Weiyong Li

Latest:

Pseudo-polymorphic conversion by near-infrared spectroscopy

Near-infrared spectroscopy (NIR) is suitable for the analysis of pharmaceutical samples in various solid forms, and can be used for determining chemical properties (e.g., content of drug, water), as well as physical properties (e.g., particle size, tablet hardness).


Holger Botsch

Latest:

The packaging connection

Creating better pharmaceutical and medical products with packaging partnerships.


Nishil Malde

Latest:

Characterizing amorphous materials with gravimetric vapour sorption techniques

Even small amounts of amorphous materials can have a significant effect on the drug product. Are gravimetric vapour sorption techniques an effective solution to characterize amorphous materials?


Eliot Chung

Latest:

LC–MS/MS method for the determination of Vitamin D3 in human plasma

An LC–MS/MS method for the quantitative determination of vitamin D3 in human plasma has been developed and validated with positive atmospheric chemical ionization sources.


Toshio Shimamoto

Latest:

Development of PVA Copolymer Capsules

The bioavailability of some insoluble drugs is enhanced when they are dissolved in the solubilizing agent macrogol 400, although conventional hard capsules cannot tolerate the agent. This article investigates a PVA copolymer, which has been developed by the authors, examining its properties and its suitability as a material in capsule formulations.


Jinghua Yuan

Latest:

Effects of Polyethylene Glycol on Morphology, Thermomechanical Properties, and Water Vapor Permeability of Cellulose Acetate-Free Films

The authors provide a systematic evaluation of the effects of solvent systems, PEG molecular weight, and concentration of CA to PEG on the thermomechanical properties and permeabilities of CA-free films.


Robert Kowal

Latest:

Monitoring Granulation Drying Using Near-Infrared Spectroscopy

A novel probe design that reduces the variation in powder-sample density also allows moisture and solvent levels to be accurately modelled and predicted...


Mathieu Dubois

Latest:

Bioanalysis of recombinant proteins by mass spectrometry

Biotechnological developments have led to an increased number of recombinant proteins or antibodies in drug development that offer high potential in various diseases, such as cancer, growth disturbances and diabetes.


Maj-Britt Babbel

Latest:

Fast dissolving disintegrating tablets with isomalt

During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.


Chan Lai Wah

Latest:

Rapid and convenient microsphere sizing

FDA advocates building quality into a product through PAT.


Jennifer Campbell

Latest:

Upcoming technologies to facilitate more efficient biologics manufacturing

The number of biotechnology-based human therapeutic products in the late-stage pipeline along with the average cost to commercialize a biotech product has been steadily increasing with time. In addition, the biotech industry is facing unprecedented challenges of a sagging global economy and rising regulatory expectations. Companies have to continue to evolve their approaches to be more efficient with respect to time, resources and cost. This article describes some of the technologies that can help optimize time and cost of biopharmaecutical manufacturing.